Natural variants of von Willebrand factor R1205 causing von Willebrand disease with accelerated von Willebrand factor clearance: In silico docking models and energetics of the interaction with both LRP1 and GpIb A1 domain.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41337046.
- Also identified by DOI 10.1371/journal.pcbi.1013458 and PMC identifier 12711066.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Type 1 von Willebrand disease (VWD) is often caused by variants in von Willebrand factor (VWF), including p.R1205H ("Vicenza mutation"), which accelerate VWF clearance via macrophage receptor LRP1 and impair platelet adhesion and activation. However, the structural mechanisms underlying these phenotypes remain partially unclear. Here, we use integrative computational modeling (I-TASSER, HADDOCK2.4, and PRODIGY) to predict how p.R1205H/C/L/S variants alter VWF interaction with LRP1 and its platelet receptor GPIbα that binds to the A1 VWF domain. Our models reveal that R1205 acts as a structural hinge: its variants disrupt polar networks in VWF's D3 domain, exposing neo-epitopes that enhance LRP1 binding (ΔΔG up to -5.3 kcal/mol) while destabilizing the A1 domain's α1-β2 loop, reducing GPIbα affinity (≅30-fold for R1205L/C). These findings explain clinical observations, p.R1205H rapid clearance yet retained platelet adhesion, and establish R1205 as a dual-functional switch regulating VWF circulatory lifetime and hemostatic activity. This analytical procedure provides a template for predicting pathogenicity of VWF variants and designing targeted therapies for VWD.
Medical subject headings
- Low Density Lipoprotein Receptor-Related Protein-1
- von Willebrand Factor
- Platelet Glycoprotein GPIb-IX Complex
- von Willebrand Diseases